======= OSBPL8 ======= == Gene Information == * **Official Symbol**: OSBPL8 * **Official Name**: oxysterol binding protein like 8 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=114882|114882]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9BZF1|Q9BZF1]] * **Interactions**: [[https://thebiogrid.org/search.php?search=OSBPL8&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20OSBPL8|Open PubMed]] * **OMIM**: [[https://omim.org/entry/606736|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Lipid transporter involved in lipid countertransport between the endoplasmic reticulum and the plasma membrane: specifically exchanges phosphatidylserine with phosphatidylinositol 4-phosphate (PI4P), delivering phosphatidylserine to the plasma membrane in exchange for PI4P, which is degraded by the SAC1/SACM1L phosphatase in the endoplasmic reticulum. Binds phosphatidylserine and PI4P in a mutually exclusive manner (PubMed:26206935). Binds oxysterol, 25- hydroxycholesterol and cholesterol (PubMed:17428193, PubMed:17991739, PubMed:21698267). {ECO:0000269|PubMed:17428193, ECO:0000269|PubMed:17991739, ECO:0000269|PubMed:21698267, ECO:0000269|PubMed:26206935}. |PH| |Oxysterol BP| |phosphatidylserine transfer activity| |protein localization to nuclear pore| |negative regulation of sequestering of triglyceride| |protein localization to nuclear envelope| |regulation of sequestering of triglyceride| |sterol binding| |sterol transporter activity| |phospholipid transporter activity| |negative regulation of lipid storage| |phosphatidylserine acyl-chain remodeling| |positive regulation of insulin receptor signaling pathway| |positive regulation of cellular response to insulin stimulus| |phosphatidylinositol-4-phosphate binding| |phosphatidylserine metabolic process| |activation of protein kinase B activity| |positive regulation of glucose import| |negative regulation of lipid localization| |positive regulation of glucose transmembrane transport| |regulation of lipid storage| |cholesterol binding| |regulation of glucose import| |phosphatidylserine binding| |regulation of insulin receptor signaling pathway| |sterol transport| |regulation of cellular response to insulin stimulus| |regulation of glucose transmembrane transport| |phospholipid transport| |fat cell differentiation| |organophosphate ester transport| |organic hydroxy compound transport| |regulation of lipid localization| |lipid binding| |protein localization to nucleus| |positive regulation of protein kinase B signaling| |cellular modified amino acid metabolic process| |positive regulation of transmembrane transport| |regulation of protein kinase B signaling| |nuclear membrane| |negative regulation of cell migration| |negative regulation of cell motility| |lipid transport| |glycerophospholipid metabolic process| |negative regulation of cellular component movement| |lipid localization| |negative regulation of locomotion| |activation of protein kinase activity| |phospholipid metabolic process| |glycerolipid metabolic process| |organic anion transport| |positive regulation of protein kinase activity| |regulation of transmembrane transport| |positive regulation of kinase activity| |anion transport| |positive regulation of transferase activity| |intracellular membrane-bounded organelle| |protein localization to organelle| |regulation of protein kinase activity| |regulation of cell migration| |regulation of kinase activity| |organophosphate metabolic process| |regulation of cell motility| |endoplasmic reticulum membrane| |cellular lipid metabolic process| |regulation of transferase activity| |regulation of locomotion| |positive regulation of transport| |regulation of cellular component movement| |positive regulation of protein phosphorylation| |positive regulation of intracellular signal transduction| |positive regulation of phosphorylation| |positive regulation of phosphorus metabolic process| |positive regulation of phosphate metabolic process| |lipid metabolic process| |positive regulation of protein modification process| |ion transport| |positive regulation of catalytic activity| |regulation of protein phosphorylation| |cellular protein localization| |regulation of phosphorylation| |cellular macromolecule localization| |positive regulation of cellular protein metabolic process| |positive regulation of signal transduction| |positive regulation of protein metabolic process| |positive regulation of molecular function| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |regulation of protein modification process| |regulation of transport| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp79|Q15 2.7μM R02 exp79]]|-3.33| |[[:results:exp164|Q15 1 to 2μM on day4 R04 exp164]]|-2.65| |[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|-1.72| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 11010 * **Expression level (log2 read counts)**: 6.58 {{:chemogenomics:nalm6 dist.png?nolink |}}